PRF Technologies PRFX
NASDAQ PRFX
$0.93 -0.03 (-3.23%)
At close: Sep 22, 2026 · 4:00 PM EDT

PRF Technologies (PRFX) Total Non-Current Liabilities (2019 - 2026)

PRF Technologies' (PRFX) quarterly Total Non-Current Liabilities came in at $271000.0 in Q2 2026, up 3.04% on a YoY basis from $263000.0 in Q2 2025, and up 1.5% quarter-over-quarter from $267000.0 in Q4 2025.

Analysis

PRF Technologies (PRFX) Total Non-Current Liabilities (2019 - 2026) Analysis & Trends

PRF Technologies (PRFX) has reported Total Non-Current Liabilities for 8 consecutive years, with $271000.0 the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Total Non-Current Liabilities rose 3.04% year-over-year to $271000.0; the trailing twelve-month figure through Jun 2026 stood at $271000.0 (up 3.04% YoY), and the FY2025 full-year result was $267000.0, up 3.09% from the prior year.
  • Total Non-Current Liabilities grew to $271000.0 in Q2 2026 per PRFX's latest filing, from $267000.0 in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $1.2 million in Q3 2023 and bottomed at $236000.0 in Q1 2022.
  • Historically, Total Non-Current Liabilities has averaged $414692.3 across 5 years, with a median of $263000.0 in 2025.
  • The sharpest annual moves came in 2023 and 2024: Total Non-Current Liabilities jumped 367.08% in 2023, then plunged 77.18% in 2024.
  • Over 5 years, Total Non-Current Liabilities stood at $243000.0 in 2022, then jumped by 367.08% to $1.1 million in 2023, then slumped by 77.18% to $259000.0 in 2024, then climbed by 3.09% to $267000.0 in 2025, then grew by 1.5% to $271000.0 in 2026.
  • According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $271000.0, $267000.0, and $263000.0 for Q2 2026, Q4 2025, and Q2 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Teva Pharmaceutical Industries 46.72 Bn 43.07 Bn 2.15 Bn 16.45 Bn
2 Viatris 19.64 Bn 18.75 Bn 1.46 Bn 18.76 Bn
3 Dr Reddys Laboratories 10.36 Bn 10.22 Bn 396.53 Mn 1.29 Mn
4 Amneal Pharmaceuticals 6.44 Bn 6.39 Bn 334.51 Mn 2.78 Bn
5 Bausch Health Companies 2.11 Bn 1.24 Bn 2.10 Bn 24.86 Bn
6 Ani Pharmaceuticals 1.88 Bn 1.52 Bn 165.89 Mn 881.37 Mn
7 Alvotech 1.83 Bn 1.69 Bn 2.56 Mn 1.45 Bn
8 Amphastar Pharmaceuticals 1.04 Bn 751.07 Mn 93.47 Mn 946.17 Mn
9 Fennec Pharmaceuticals 382.22 Mn 340.97 Mn 17.15 Mn 20.92 Mn
10 PRF Technologies 622,054.07 -10.31 Mn - 271,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 271,000.00
Dec 31, 2025 267,000.00
Jun 30, 2025 263,000.00
Dec 31, 2024 259,000.00
Jun 30, 2024 257,000.00
Mar 31, 2024 268,000.00
Dec 31, 2023 1.14 Mn
Sep 30, 2023 1.15 Mn
Jun 30, 2023 247,000.00
Mar 31, 2023 245,000.00
Dec 31, 2022 243,000.00
Jun 30, 2022 549,000.00
Mar 31, 2022 236,000.00
Dec 31, 2021 234,000.00
Jun 30, 2021 613,000.00
Mar 31, 2021 213,000.00
Dec 31, 2020 220,000.00
Sep 30, 2020 -1.07 Mn
Jun 30, 2020 1.51 Mn
Mar 31, 2020 -802,000.00
API Access

PRF Technologies Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=PRFX&period=max&api_key=YOUR_API_KEY